Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul;36(4):1343-1372.
doi: 10.1007/s13577-023-00915-5. Epub 2023 May 20.

Roles of non-coding RNAs in the metabolism and pathogenesis of bladder cancer

Affiliations
Review

Roles of non-coding RNAs in the metabolism and pathogenesis of bladder cancer

Daniel Ruben Akiola Sanya et al. Hum Cell. 2023 Jul.

Abstract

Bladder cancer (BC) is featured as the second most common malignancy of the urinary tract worldwide with few treatments leading to high incidence and mortality. It stayed a virtually intractable disease, and efforts to identify innovative and effective therapies are urgently needed. At present, more and more evidence shows the importance of non-coding RNA (ncRNA) for disease-related study, diagnosis, and treatment of diverse types of malignancies. Recent evidence suggests that dysregulated functions of ncRNAs are closely associated with the pathogenesis of numerous cancers including BC. The detailed mechanisms underlying the dysregulated role of ncRNAs in cancer progression are still not fully understood. This review mainly summarizes recent findings on regulatory mechanisms of the ncRNAs, long non-coding RNAs, microRNAs, and circular RNAs, in cancer progression or suppression and focuses on the predictive values of ncRNAs-related signatures in BC clinical outcomes. A deeper understanding of the ncRNA interactive network could be compelling framework for developing biomarker-guided clinical trials.

Keywords: Bladder cancer; Circular RNAs; Long non-coding RNAs; microRNAs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. ‘Cancer statistics, 2022.’ CA Cancer J Clin. 2022;72(1):7–33. - PubMed - DOI
    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. ‘Cancer Statistics, 2021.’ CA Cancer J Clin. 2021;71(1):7–33. - PubMed - DOI
    1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53. - PubMed - DOI
    1. Hanna KS. A review of immune checkpoint inhibitors for the management of locally advanced or metastatic urothelial carcinoma. Pharmacotherapy. 2017;37(11):1391–405. - PubMed - DOI
    1. Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, Lotan Y. Bladder cancer. Nat Rev Dis Primers. 2017;3(1):17022. - PubMed - DOI

MeSH terms

LinkOut - more resources